Received: 12 November 2020
Accepted: 10 January 2021
First Online: 12 April 2021
Ethics approval and consent to participate
: The present investigation was approved by the ethics committee of The Fifth Hospital of Wuhan. All experiments are performed after the consent of the patients or family members.
: We would like to submit the enclosed manuscript entitled “LncRNA ACTA2-AS1 suppress colon adenocarcinoma progression by sponging miR-4428 upregulation <i>BCL2L11</i>”, which we wish to be considered for publication in <i>Cancer Cell International</i>.
: The authors report no conflicts of interest in this work.